COARAVEN 300/12.5 MG BOX OF 90

Treatment of essential arterial hypertension. This fixed-dose combination is indicated in adult patients whose blood pressure is insufficiently controlled by irbesartan alone or hydrochlorothiazide alone.

Category: Cardio-Metabolic

Description
Reviews (0)

Description

Specialty	COARAVEN
Dosage	12.5 mg, 300 mg
Form	Film-coated tablet
Presentation	Box of 90
Primary packaging	Blister
Specification	Opaque white PVC/PVDC/Alu
INN	HYDROCHLOROTHIAZIDE, IRBESARTAN
VEIC Classification	Essential
Therapeutic class	CARDIOVASCULAR SYSTEM
Subclass	Agents acting on the renin-angiotensin system
Laboratory	PHILADELPHIA PHARMA
Schedule	A
Shelf life	24 months
Generic/Originator	Generic
Marketing Authorization (MA)	9353049
MA date	2014-08-12
Range	Cardio-Metabolic Range